Mr Eleftherios Agorogiannis is a consultant ophthalmologist, uveitis and medical retina specialist, and cataract surgeon. He graduated first in his class from the University of Thessaly Medical School, Greece, and subsequently attained a Doctor of Philosophy degree in transplantation immunology from the University of Oxford.
Mr Agorogiannis completed his ophthalmology specialist training in Liverpool, and a fellowship in medical retina and uveitis at Moorfields Eye Hospital, London. Before joining Manchester Royal Eye Hospital in 2022, Mr Agorogiannis was a consultant ophthalmologist at Oxford Eye Hospital. Mr Agorogiannis is the lead for adult uveitis research at Manchester Royal Eye Hospital, and has an interest in biomarkers of immunosuppression and immune profiling of patients with non-infectious uveitis. In addition to his NHS duties, Mr Agorogiannis is an associate editor at BMJ Open Ophthalmology and a review editor at Frontiers in Ophthalmology.
Furthermore, he is a member of the Royal College of Ophthalmologists medical retina expert group on prevalence and incidence of eye conditions and workforce composition, and he is an examiner for FRCOphth. Mr Agorogiannis is an expert in managing ocular inflammation (uveitis and scleritis), including complex disease requiring systemic immunosuppression. In addition, he is experienced in treating patients with age-related macular degeneration, retinal vascular diseases (including diabetic retinopathy, diabetic macular oedema, and retinal vein occlusions), and other retinal disorders amenable to non-surgical management. Mr Agorogiannis offers a variety of treatments, including intravitreal steroid and anti-VEGF injections, cataract surgery, laser capsulotomy, and retinal laser treatment.
